Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives (Q39049420)

8 September 2017

title

Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives (English)

1 reference

8 September 2017

main subject

anti-retroviral agent

0 references

0 references

2

Rony Zachariah

1 reference

8 September 2017

5

Mina C Hosseinipour

1 reference

8 September 2017

1

Anthony D Harries

1 reference

8 September 2017

8

Andreas Jahn

1 reference

8 September 2017

10

Kelita Kamoto

1 reference

8 September 2017

Joep J van Oosterhout

series ordinal

3

object named as

Joep J van Oosterhout

1 reference

8 September 2017

7

Zengani Chirwa

1 reference

8 September 2017

Steven D Reid

4

1 reference

8 September 2017

Vic Arendt

series ordinal

6

1 reference

8 September 2017

Erik J Schouten

series ordinal

9

1 reference

8 September 2017

publication date

1 January 2010

1 reference

Lancet Infectious Diseases

8 September 2017

published in

1 reference

8 September 2017

volume

10

1 reference

8 September 2017

issue

1

1 reference

8 September 2017

page(s)

60-65

1 reference

British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Lessons learned from use of highly active antiretroviral therapy in Africa

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Antiretroviral therapy and early mortality in South Africa

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Low Levels of Antiretroviral‐Resistant HIV Infection in a Routine Clinic in Cameroon that Uses the World Health Organization (WHO) Public Health Approach to Monitor Antiretroviral Treatment and Adequacy with the WHO Recommendation for Second‐Line

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Response to antiretroviral therapy after a single, peripartum dose of nevirapine

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Mortality and virologic outcomes after access to antiretroviral therapy among a cohort of HIV-infected women who received single-dose nevirapine in Lusaka, Zambia

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Should active recruitment of health workers from sub-Saharan Africa be viewed as a crime?

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Traditional healers and their practices in Malawi

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Immune reconstitution disease: recent developments and implications for antiretroviral treatment in resource-limited settings

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

CD4 T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Viraemia and HIV-1 drug resistance mutations among patients receiving antiretroviral treatment in Mozambique

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infected African patients

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

HIV-1 viral load monitoring: an opportunity to reinforce treatment adherence in a resource-limited setting in Thailand

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Rapid expansion of the health workforce in response to the HIV epidemic

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Protease inhibitor-based regimens for HIV therapy: safety and efficacy.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Different delivery models for antiretroviral therapy in sub-Saharan Africa in the context of 'universal access'.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Effect of early versus deferred antiretroviral therapy for HIV on survival

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Initiation of HAART at higher CD4 cell counts is associated with a lower frequency of antiretroviral drug resistance mutations at virologic failure

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

Monitoring HIV antiretroviral therapy in resource-limited settings: time to avoid costly outcomes

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(09)70321-4

7 January 2021

10.1016/S1473-3099(09)70321-4

Identifiers

DOI

1 reference

8 September 2017

1 reference